The National Academy of Medicine (NAM) today announced the election of 90 regular members and 10 international members during its annual meeting. Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.
“It is my honor to welcome this truly exceptional class of new members to the National Academy of Medicine,” said NAM President Victor J. Dzau. “Their contributions to health and medicine are unparalleled, and their leadership and expertise will be essential to helping the NAM tackle today’s urgent health challenges, inform the future of health care, and ensure health equity for the benefit of all around the globe.”
New members are elected by current members through a process that recognizes individuals who have made major contributions to the advancement of the medical sciences, health care, and public health. A diversity of talent among NAM’s membership is assured by its Articles of Organization, which stipulate that at least one-quarter of the membership is selected from fields outside the health professions — for example, from such fields as law, engineering, social sciences, and the humanities. The newly elected members bring NAM’s total membership to more than 2,400, which includes 198 international members.
Established originally as the Institute of Medicine in 1970 by the National Academy of Sciences, the National Academy of Medicine addresses critical issues in health, science, medicine, and related policy and inspires positive actions across sectors. NAM works alongside the National Academy of Sciences and National Academy of Engineering to provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions. The National Academies of Sciences, Engineering, and Medicine also encourage education and research, recognize outstanding contributions to knowledge, and increase public understanding of STEMM. With their election, NAM members make a commitment to volunteer their service in National Academies activities.
Newly elected regular members of the National Academy of Medicine and their election citations are:
Daniel G. Anderson, PhD, professor, department of chemical engineering, Institute for Medical Engineering and Science, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge. For pioneering the area of non-viral gene therapy and cellular delivery. His work has resulted in fundamental scientific advances, over 500 papers, patents, and patent applications, and the creation of companies, products, and technologies that are now in the clinic.
Kimberly Dawn Anderson-Erisman, PhD, professor, physical medicine and rehabilitation, Case Western Reserve University/MetroHealth System, Cleveland. For her 2004 seminal publication that challenged the dogma that ambulation was the top priority for people living with spinal cord injury (SCI), and redirection of SCI research toward upper limb, bowel, and bladder function. More recently, she led efforts to ensure that people with SCI participate in SCI research teams.
Michael S. Avidan, MB BCh, FCA SA, Dr. Seymour and Rose T. Brown Professor of Anesthesiology, head of the department of anesthesiology, and professor of psychiatry and surgery, Washington University School of Medicine, St. Louis. For his international leadership in clinical anesthesiology research. He has designed and led large-scale, pragmatic clinical trials that have elucidated the role of clinical monitoring in the prevention of intraoperative awareness and delirium as well as the relationship of general anesthesia to neurocognitive outcomes of surgery.
Karen Bandeen-Roche, PhD, professor and emeritus chair, biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore. For enhancing the health and quality of life for older adults by developing innovative quantitative methods to improve measurements of complex disease states and to learn about patient trajectories and risks of major adverse events. Her methods have significantly advanced our understanding of functional capacity, disability, and frailty in aging.
Kurt Barnhart, MD, MSCE, William Shippen Jr. Professor of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia. For establishing the standard of care for early pregnancy monitoring, and for pioneering novel management protocols to decrease morbidity from pregnancy-related complications and early pregnancy loss including ectopic pregnancy, which is the leading cause of first trimester maternal mortality worldwide.
Regina Barzilay, MS, PhD, School of Engineering Distinguished Professor of AI and Health, and AI lead, Jameel Clinic for Machine Learning and Health, Massachusetts Institute of Technology, Cambridge. For the development of machine learning tools that have been transformational for breast cancer screening and risk assessment, and for the development of molecular design tools broadly utilized for drug discovery.
Susan J. Baserga, MD, PhD, professor of molecular biophysics and biochemistry, of genetics, and of therapeutic radiology, molecular biophysics, and biochemistry, Yale University, New Haven, Conn. For pioneering the understanding of how ribosomes, the molecular factories that make proteins, assemble inside cells. Using a battery of approaches, she discovered a huge multi-molecular machine essential for ribosome formation in the cell nucleus. Components of this “processome” are implicated in a number of inherited human diseases.
Rashid Bashir, PhD, Grainger Distinguished Chair in Engineering, professor of bioengineering, University of Illinois at Urbana-Champaign, Champaign. For seminal contributions and visionary leadership in micro and nanoscale biosensors and diagnostics, bioengineering for early detection of infection and sepsis, and education in engineering-based medicine by helping to establish the world’s first engineering-based medical school at UIUC.
Bradley Bernstein, MD, PhD, chair of cancer biology and Richard and Nancy Lubin Family Chair, Dana-Farber Cancer Institute; and professor, departments of cell biology and pathology, Harvard Medical School, Boston. For landmark contributions to our understanding of chromatin structure and function, including the establishment of principles of gene poising, repression and long-range regulation, and the identification of epigenetic mechanisms that underlie stem cell potency and tumorigenesis.
Joseph R. Betancourt, MD, MPH, president, The Commonwealth Fund, New York City. For leading one of nation’s foremost health care philanthropies, and being one of the nation’s most accomplished and experienced scholars and practitioners of health care quality and equity improvement.
Marian E. Betz, MD, MPH, professor, emergency medicine, and founding director, Firearm Injury Prevention Initiative, University of Colorado, Aurora. For her firearms and suicide prevention expertise and engagement with community members, including gun owners and retailers, in developing interventions to save lives from firearm injuries. She leads groundbreaking research in injury prevention and has been an expert for national organizations and three White House administrations.
Sara Naomi Bleich, PhD, professor of public health policy, department of health policy and management, and vice provost for special projects, Harvard T.H. Chan School of Public Health, Harvard University, Boston. For her internationally renowned expertise on nutrition security, and for being an advocate for health equity. She is widely recognized for her leadership and policy-relevant research on prevention of obesity and other diet-related diseases, food insecurity, racial inequities in the U.S., and advancing equitable policy solutions for change.
John D. Carpten, PhD, chief scientific officer, City of Hope, Duarte, Calif. For leading the genomics field in understanding how racial and ethnic backgrounds affect cancer predisposition. He is internationally recognized for research in functional genomics, health disparities, and precision medicine. He has numerous national leadership roles and is the first African American to chair the National Cancer Advisory Committee.
Patrick M. Carter, MD, co-director, Institute for Firearm Injury Prevention; co-director, Injury Prevention Center; associate professor, department of emergency medicine, Medical School; and associate professor, department of health behavior and health education, School of Public Health, University of Michigan, Ann Arbor. For research and scholarship within the field of firearm injury prevention, including directing an Institute that is dedicated to advancing research on prevention-focused solutions to this public health problem, leading the NIH-funded Community Firearm Violence Prevention Network Coordinating Center, and directing a firearm injury prevention postdoctoral training program.
Timothy A. Chan, MD, PhD, chair, Global Center for Immunotherapy and Precision Immuno-Oncology; Sheikha Fatima Bint Mubarak Chair; and professor of medicine, Cleveland Clinic and Case Western Reserve University, Cleveland. For playing a key role in establishing the relationship between the number of mutations in a patient’s tumor and the success of immune checkpoint inhibitors.
Michael F. Chiang, MD, MA, director, National Eye Institute, National Institutes of Health, Bethesda, Md. For pioneering applications of biomedical informatics to ophthalmology in artificial intelligence, telehealth, pediatric retinal disease, electronic health records, and data science, including methodological and diagnostic advances in AI for pediatric retinopathy of prematurity, and for contributions to developing and implementing the largest ambulatory care registry in the United States.
Tumaini Rucker Coker, MD, MBA, professor and division head, general pediatrics, University of Washington, Seattle Children’s Hospital. For her leadership in advancing child health equity through scholarship in community-partnered design of innovative care models in pediatric primary care. Her work has transformed our understanding of how to deliver child preventive health care during the critical early childhood period to achieve equitable health outcomes and reduce disparities.
Theodore J. Corbin, MD, MPP, The Carol A. and Leo M. Henikoff, MD Presidential Professor; chairperson and professor, department of emergency medicine, Rush University Medical Center, Chicago. For his national leadership in firearm injury prevention. He focuses on community violence prevention and policy, has received numerous awards for his leadership, and currently serves as co-chair of the NAM Task Force on Preventing Firearm Injury and Violence.
Deidra C. Crews, MD, ScM, professor of medicine (nephrology), epidemiology, and nursing, Johns Hopkins University School of Medicine, Baltimore. For advancing equity and the social epidemiology of kidney disease. She has elucidated root causes of the disproportionate kidney disease burden among socially marginalized populations; used interventions to address social and behavioral risk factors for adverse outcomes; and informed guidelines for optimizing care for people with kidney failure.
Karina W. Davidson, PhD, MASc, senior vice president of research, Northwell Health; dean of academic affairs, Feinstein Institutes of Medical Research at Northwell Health; and Zucker Endowed Professor in Health Outcomes, departments of medicine, psychiatry, and cardiology, Zucker School of Medicine at Hofstra University/Northwell Health, New Hyde Park, N.Y. For being an influential implementation scientist, trialist, and practitioner of evidence-based behavioral medicine. As a central leader of national and global collaboratives, she has improved public health significantly by investigating the causal effects of behavior change. As chair of the U.S. Preventive Services Task Force, she affected the health care of millions.
Roger J. Davis, PhD, FRS, professor and chair, program in molecular medicine, University of Massachusetts Chan Medical School, Worcester. For his research leadership on mechanisms that mediate cellular stress responses. His seminal discoveries on the c-Jun NH2-terminal kinase (JNK) signaling pathway provide a foundation for understanding the molecular basis of metabolic inflammatory responses in the development of obesity, metabolic syndrome, and type 2 diabetes.
Luis Alberto Diaz Jr., MD, head, division of solid tumor oncology, department of medicine, Memorial Sloan Kettering Cancer Center, New York City. For pioneering efforts to provide the first definitive examples of circulating tumor DNA being successfully used as a cancer biomarker for screening, monitoring, and detection of occult disease, and for discovery of the therapeutic link between immunotherapy and genetics in Lynch Syndrome patients and others with mismatch repair-deficient tumors.
Gail D’Onofrio, MD, MS, Albert E. Kent Professor of Emergency Medicine, Yale School of Medicine; and professor of medicine core addiction and professor of epidemiology, Yale School of Public Health, New Haven, Conn. For foreseeing the exploding opioid misuse epidemic, identifying the opportunity during emergency care, and developing knowledge and policy to change the practice. Her studies on alcohol-related seizures, alcohol interventions, and emergency department-initiated buprenorphine are transformative. Her implementation science studies enhanced the migration of research into practice.
Kojo Seys John Elenitoba-Johnson, MD, inaugural chair, department of pathology and laboratory medicine, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York City. For pioneering lymphoma proteomics and being a top leader in precision and integrated diagnostics and their global democratization. His discoveries of therapeutically relevant recurrent genetic alterations and unbiased proteomic characterization of lymphoma have directly impacted patient care.
Sarah K. England, PhD, Alan A. and Edith L. Wolff Professor of Medicine, department of obstetrics and gynecology, Washington University School of Medicine, St. Louis. For contributions to the basic understanding of processes that underlie aberrant uterine activity leading to parturition and preterm birth.
M. Daniele Fallin, PhD, James W. Curran Dean of Public Health, Rollins School of Public Health, Emory University, Atlanta. For being an international leader in elucidating genetic, epigenetic, and environmental mechanisms for neuropsychiatric and developmental disorders, particularly autism, Alzheimer’s disease, and schizophrenia. As dean of public health at the Emory Rollins School, she contributes to population health efforts to recognize, understand, and prevent these neglected diseases.
Maurizio Fava, MD, chair, department of psychiatry, associate dean for clinical and translational research, and Slater Family Professor of Psychiatry, Harvard Medical School, Boston. For having contributed to the development of many novel antidepressant compounds throughout his career. He received research funding for over $110 million during the past 10 fiscal years, and has authored or co-authored over 900 original articles, with over 100,000 citations and an h index over 150.
Guoping Feng, PhD, James W. (1963) and Patricia T. Poitras Professor, brain and cognitive science; director, model systems and neurobiology, Stanley Center for Psychiatric Research; and Tan Yang Collective researcher and associate director, McGovern Institute for Brain Research, Massachusetts Institute of Technology; and member, Broad Institute of MIT and Harvard, Cambridge. For his breakthrough discoveries regarding the pathological mechanisms of neurodevelopmental and psychiatric disorders, providing foundational knowledges and molecular targets for developing effective therapeutics for mental illness such as OCD, ASD, and ADHD.
Sandy Feng, MD, PhD, professor of surgery in residence, and vice chair of research, department of surgery, University of California, San Francisco. For challenging the dogma of lifelong immunosuppression and reshaping the paradigm for the long-term management of people with liver transplants. Her leadership in ethics of deceased donor intervention is opening the door for innovative research to improve the quality and quantity of life-saving organs available for transplantation.
Christopher B. Forrest, MD, PhD, professor of pediatrics, Children’s Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia. For revolutionizing pediatric applied clinical research by founding PEDSnet, a network of 11 children’s hospitals that share clinical data and a >13 million patient database, providing uniquely large sample sizes for common and rare diseases, a model data-management infrastructure for pediatric clinical research, and a unique research training program.
Debra M. Furr-Holden, PhD, dean and professor of epidemiology, New York University School of Global Public Health, New York City. For her community-partnered research that has fueled multiple policy initiatives to improve behavioral health and eliminate racial, economic, and geographic disparities in intentional and unintentional injury including opioid-involved overdose death, gun violence, and community violence.
Susan L. Furth, MD, PhD, chief scientific officer, executive vice president, and Edmond F. Notebaert Endowed Chair in Pediatric Research, Children’s Hospital of Philadelphia; and professor, department of pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia. For defining the natural history and epidemiology of kidney disease in children, including rates of progression, and elucidating the impact of cardiovascular disease risk by race, social determinants, and cause of kidney disease through multi-center observational studies and randomized control trials. Her work has substantially impacted children’s health.
Richard L. Gallo, MD, PhD, distinguished professor and founding chair, department of dermatology, University of California, San Diego. For discovering that the skin produces antimicrobial peptides and acts with the microbiome to protect against infection and regulate inflammation. His seminal observations in these fields have uncovered aspects of the pathogenesis of several diseases including atopic dermatitis, rosacea, and psoriasis, improving current approaches to therapy.
Francisco A.R. García, MD, MPH, deputy county administrator and chief medical officer, Pima County; and professor emeritus of public health, University of Arizona, Tucson. For being an internationally recognized expert in border health, emergency preparedness, and women’s reproductive health with more than 24 years of experience in public health and human services administration. He leads teams that develop innovative, collaborative, multi-sectoral approaches to the complex problems in vulnerable communities.
Cheryl L. Giscombe, PhD, PMHNP, RN, FAAN, FABMR, distinguished tenured professor and interim senior associate dean of academic affairs, School of Nursing, University of North Carolina, Chapel Hill. For influencing national guidelines as a leading scholar on mental health, resilience, clinician wellness, and mind-body research. Her groundbreaking accomplishments include development of the Interprofessional Leadership Institute for Mental Health Equity, the “Superwoman Schema” theory, and biopsychosocial solutions for stress-related health inequities.
Céline R. Gounder, MD, senior fellow and editor-at-large for public health, KFF Health News; medical contributor, CBS News; and clinical associate professor of internal medicine and infectious diseases, New York University Grossman School of Medicine and NYC Health + Hospitals/Bellevue, New York City. For being one of the world’s leading experts in communication about science, medicine, and public health. She has won awards for coverage of health inequities and the COVID, Ebola, Zika, opioid, gun-violence, and disinformation epidemics.
David C. Grabowski, PhD, professor, health care policy, Harvard Medical School, Boston. For his leadership, prominence, and contributions to the field of health economics, for elucidating novel trends in long-term and post-acute care quality, and identifying contradictory payment policies for Medicare and Medicaid, and for his work on the determinants of COVID-19 in nursing home deaths resulting in policy changes.
Eric D. Green, MD, PhD, director, National Human Genome Research Institute (NHGRI), National Institutes of Health, Bethesda, Md. For leading the development of technologies and tools for translating genomics to clinical practice. Globally, he has pioneered cooperation to advance genomic fluency and precision medicine. In parallel, he has modeled diversity and inclusion in NHGRI senior leadership and workforce training programs.
Justin Hanes, PhD, Lewis J. Ort Professor of Ophthalmology, Wilmer Eye Institute, and professor of biomedical engineering, chemical and biomolecular engineering, neurosurgery, oncology, and pharmacology and molecular sciences, Johns Hopkins University, Baltimore. For pioneering discoveries and inventions of innovative drug delivery technologies, especially mucosal, ocular, and central nervous system drug delivery systems; and for international leadership in research and education at the interface of engineering, medicine, and entrepreneurship, leading to clinical translation of drug delivery technologies.
Richard J. Hatchett, MD, chief executive officer, Coalition for Epidemic Preparedness Innovations (CEPI), Oslo, Norway. For extraordinary leadership in national and global public health preparedness. His many contributions include conceiving the Medical Reserve Corps after 9/11, pioneering social distancing strategies, helping to lead the 2009 Influenza Pandemic response, serving as first CEO of CEPI, and advancing equitable COVID-19 vaccine distribution by co-founding COVAX.
Jiang He, MD, PhD, professor and Joseph S. Copes Chair in Epidemiology, and director, Translational Science Institute, Tulane University, New Orleans. For transforming cardiovascular disease (CVD) prevention efforts worldwide. After landmark studies documenting key determinants for CVD in the U.S., China, and elsewhere, he designed and rigorously tested highly effective and scalable interventions in resource-constrained settings. His research is creative, impactful, and transformative on a global scale.
Said A. Ibrahim, MD, MPH, MBA, senior vice president, medicine service line; chair, department of medicine; and David J. Greene Professor of Medicine, Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, N.Y. For his seminal health services research on racial disparities in elective joint replacement that has provided a national model for advancing health equity research beyond the identification of inequities and toward their remediation, and for his research that has been leveraged to engage diverse and innovative emerging scholars.
Thomas V. Inglesby, MD, director, Center for Health Security, and professor, department of environmental health and engineering, Johns Hopkins Bloomberg School of Public Health; and joint appointment in medicine, Johns Hopkins School of Medicine, Baltimore. For helping to establish and shape the field of public health preparedness and response, and for being an internationally respected voice during COVID. He’s been a public health leader for U.S. Department of Health and Human Services and the White House and influenced national and international policy, creating valuable collaborations and networks around the world.
Darrell J. Irvine, PhD, Underwood-Prescott Professor, department of biological engineering and department of materials science and engineering, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge. For the development of novel methods for delivery of immunotherapies and vaccines for cancer and infectious diseases.
Ursula B. Kaiser, MD, chief, division of endocrinology, diabetes, and hypertension, and George W. Thorn, MD, Distinguished Chair in Endocrinology, Brigham and Women’s Hospital; and professor of medicine, Harvard Medical School, Boston. For being an internationally recognized leader in reproductive neuroendocrinology. Her major scientific accomplishments include the unraveling of genetic and molecular mechanisms controlling pubertal timing and gonadotropin-releasing hormone activation and the regulation of luteinizing hormone and follicle-stimulating hormone secretion.
Joneigh S. Khaldun, MD, MPH, FACEP, vice president and chief health equity officer, CVS Health, and staff physician, Henry Ford Health, Detroit. For her national leadership in emergency medicine and public health and advancing effective strategies to improve the health of historically marginalized populations. She led Michigan’s COVID-19 response, as well as the Detroit Health Department’s strategy contributing to the city’s lowest recorded infant mortality rate. As an appointee to President Biden’s COVID-19 Health Equity Task Force, she helped advance recommendations for improving the country’s response to current and future pandemics.
Christopher F. Koller, MPPM, MAR, president, Milbank Memorial Fund, New York City. For influencing the alignment of private and public health care policy to achieve systemic progress in population health and cost-effectiveness. The reforms he led as Rhode Island’s Health Insurance Commissioner have had national influence.
Wilbur A. Lam, MD, PhD, professor and W. Paul Bowers Research Chair, Wallace H. Coulter Department of Biomedical Engineering, Emory University and Georgia Institute of Technology; and professor, department of pediatrics, and associate dean of innovation, Emory University School of Medicine, Atlanta. For outstanding contributions in blood biophysics, in vitro models of hematologic diseases, and point-of-care, home-based, and/or smartphone-enabled diagnostics that are changing the management of pediatric and blood disorders. He also leads efforts to assess diagnostic tests (including those used during the COVID-19 pandemic) for the NIH and entire country.
Steven D. Leach, MD, professor of molecular and systems biology, surgery, and medicine; Preston T. and Virginia R. Kelsey Distinguished Chair in Cancer; and director, Dartmouth Cancer Center, Dartmouth Geisel School of Medicine, Lebanon, N.H. For being an international leader in pancreatic cancer research, having made seminal research contributions in pancreatic cancer surgery, biology, genomics, and therapy over the past three decades.
Jeannie T. Lee, MD, PhD, professor of genetics, department of molecular biology, Massachusetts General Hospital; and department of genetics, Harvard Medical School, Boston. For research that has been central for understanding the roles of non-coding RNA in gene regulation. Using X-chromosome inactivation as a model, her investigations into extensive transcription of non-coding RNA are uncovering potential therapeutics to treat human diseases, including autism spectrum disorders, Rett Syndrome, and Fragile X Syndrome.
Lois K. Lee, MD, MPH, associate professor of pediatrics and emergency medicine, Harvard Medical School; and senior associate in pediatrics, division of emergency medicine, Boston Children’s Hospital, Boston. For foundational research on firearm injuries and being the lead author for the American Academy of Pediatrics 2022 Technical Report/Policy Statement on pediatric firearm injury prevention. In an area lacking major research support, she conducted and translated rigorous injury science for policymakers, leading to thousands of prevented injuries.
Kirsten E. Lyke, MD, professor of medicine, Center for Vaccine Development and Global Health, and director, Malaria Vaccine and Challenge Unit, University of Maryland, Baltimore. For internationally recognized contributions to vaccine development against global (malaria and dengue) and emerging (Ebola and COVID-19) infectious diseases, and for leadership in human challenge models, optimizing and operationalizing tools that allow down-selection of candidate vaccines and monoclonal antibodies against malaria and dengue.
Yvonne (Bonnie) Maldonado, MD, Taube Professor of Global Health and Infectious Diseases; professor of pediatrics and epidemiology and population health, Stanford University, Stanford, Calif. For her contributions in the epidemiology and control of pediatric infectious diseases, including polio and measles elimination from the Americas, prevention of maternal-infant HIV transmission, and the national COVID-19 pandemic response. She is a first-generation Latina and a role model for her academic accomplishments.
Miriam Merad, MD, PhD, chair, department of immunology and immunotherapy, and director, Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York City. For her groundbreaking discoveries in immunology, establishing for the first time that tissue-resident macrophages form an independent lineage that arises and is maintained independently of adult hematopoiesis, and have unique functional attributes that promote tissue integrity and tissue repair, response to infection, and contribute to tumor outcome.
Timothy M. Miller, MD, PhD, David Clayson Professor of Neurology and vice chair of research, Washington University, St. Louis. For defining pathophysiology and developing a novel RNA-targeted therapeutic approach for treating neurological diseases, which he has pioneered and shown successful in amyotrophic lateral sclerosis and dementias. His blueprint for drug design and clinical trial application is now serving as a model in other neurologic disease programs.
Robert Avery Montgomery, MD, DPhil, FACS, H. Leon Pachter Chair and professor of surgery, department of surgery, and director, NYU Langone Transplant Institute, NYU Langone Health, New York City. For significant contributions to the field of transplantation. He led the team that performed the first successful genetically edited pig-to-human kidney xenotransplant. He invented the type of “kidney swap” that is responsible for over a thousand kidney transplants a year.
Gerardo Moreno, MD, MSHS, chair and professor, department of family medicine, University of California, Los Angeles. For being one of the most influential young Latino academic leaders in family medicine and health care. He has implemented successful research initiatives and programs that enable and mentor minority students and advocates for state and federal policies that diversify the health care workforce, anchored in caring for high-risk patients in underserved communities.
Siddhartha Mukherjee, MD, DPhil, associate professor of medicine, department of medicine, division of oncology, Columbia University of Medicine, New York City. For contributing important research in the immunotherapy of myeloid malignancies, such as acute myeloid leukemia, for establishing international centers for immunotherapy for childhood cancers, and for the discovery of tissue-resident stem cells. His book, “The Emperor of All Maladies,” won the Pulitzer Prize and was nominated by Time as one of the century’s 100 most influential books, introducing millions to modern cancer research.
Lisa A. Newman, MD, MPH, professor of surgery, chief, breast surgery section, and executive director and founder, International Center for the Study of Breast Cancer Subtypes, Weill Cornell Medicine and New York Presbyterian Hospital Network, New York City. For her efforts to address and eliminate breast cancer disparities across the world and whose research on characterizing hereditary susceptibility for triple negative breast cancer associated with African ancestry have earned worldwide acclaim.
Igho Ofotokun, MD, MSc, FIDSA, Grady Distinguished Professor of Medicine, School of Medicine, and professor of behavioral, social, and health education sciences, Rollins School of Public Health, Emory University, Atlanta. For being a leading authority on the burden of chronic HIV and other infections in vulnerable populations. He promotes innovative strategies to mitigate this burden and enhance healthy aging. He leverages his platform to promote women and minorities in the biomedical workforce globally.
Herminia Palacio, MD, MPH, president and CEO, Guttmacher Institute, New York City. For advancing health care delivery in the U.S. through leadership roles in nonprofits, government, philanthropy, and academia. As examples, she leads one of the most important research and policy institutes for reproductive rights in the U.S. and developed a health access program in New York City serving over 100,000 people.
Desmond U. Patton, PhD, MSW, Schwartz University Professor of Social Policy, Communications, and Psychiatry; founding director, SAFElab; and chief strategy officer, School of Social Policy and Practice, University of Pennsylvania, Philadelphia. For being the founding director of the SAFElab, a research lab focused on the ways in which youth of color navigate violence online and offline. He combines innovative and rigorous data science and social work approaches to understand the mechanisms of violence, firearm violence, joy, and grief.
Raina K. Plowright, PhD, Rudolf J. and Katharine L. Steffen Professor, department of public and ecosystem health, College of Veterinary Medicine, Cornell Atkinson Center for Sustainability, Cornell University, Ithaca, N.Y. For leadership in studying the impact of climate and land use change on infectious diseases emergence. She defined the spatial and temporal mechanisms underlying spillover of Hendra virus from bats into domestic animal and human populations. Her mechanistic work at the interface of ecology and disease is critical for preventing future pandemics.
Keshia M. Pollack Porter, PhD, MPH, Bloomberg Centennial Professor and Bloomberg Centennial Chair, department of health policy and management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore. For her national leadership and major contributions to research, practice, and education related to health in all policies, and development of methodologies that promote health and equity considerations in policy decisions across multiple sectors, including transportation, housing, and education.
Kristy Red-Horse, PhD, investigator, Howard Hughes Medical Institute; and professor, department of biology, and professor, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, Calif. For research on how coronary vessels of the heart develop during embryogenesis and how they regenerate following cardiac injury. Her long-term goal is to discover novel developmental mechanisms while contributing knowledge toward the advancement of clinical treatments for cardiovascular disease.
Teri Reynolds, MD, MS, PhD, unit head, World Health Organization, Geneva, Switzerland. For establishing the first WHO emergency care program and developing WHO’s Basic Emergency Care and Global Emergency and Trauma Care Initiative, active in 60 countries. She leads WHO’s guidance on universal health coverage packages and essential health services during crisis. Her academic contributions include extraordinary research collaborations across Africa and beyond.
Joseph B. Richardson Jr., PhD, MA, MPower Professor of African American Studies and Anthropology, department of African American studies and department of anthropology, University of Maryland, College Park. For being a nationally and internationally recognized pioneer in research on gun violence, firearm injury, trauma, and interventions. His work includes translating science into the development of innovative interventions to reduce gun violence and firearm-related morbidity and mortality, especially as it impacts youth in poverty and Black men.
Lainie Friedman Ross, MD, PhD, dean’s professor and chair, department of health humanities and bioethics, director, Paul M. Schyve MD Center for Bioethics, and professor, departments of pediatrics and philosophy, University of Rochester, Rochester, N.Y.; and Carolyn and Matthew Bucksbaum Professor Emerita, University of Chicago. For her role in developing the living kidney paired exchange program, which now accounts for over 1,000 kidney transplants annually. Ross has also proposed a pediatric decision-making framework that is one of four models incorporated into the American Academy of Pediatrics policy on decision-making in pediatric practice.
Ali Rowhani-Rahbar, MD, MPH, PhD, Bartley Dobb Endowed Professor for the Study and Prevention of Violence, department of epidemiology, University of Washington, Seattle. For being a national public health leader whose innovative and multidisciplinary research to integrate data across the health care system and criminal legal system has deepened our understanding of the risk and consequences of firearm-related harm and informed policies and programs to reduce its burden especially among underserved communities and populations.
Mustafa Sahin, MD, PhD, professor, department of neurology, Boston Children’s Hospital, Boston. For world-leading expertise in the neurobiology of autism and a pioneer in translational studies for neurogenetic disorders. Work in the Sahin lab has identified the mechanisms by which tuberous sclerosis leads to neuronal mis-wiring and led to the identification of potential therapies for this and related disorders.
Joseph V. Sakran, MD, MPH, MPA, FACS, executive vice chair of surgery and director of clinical operations, and associate professor of surgery and nursing, Johns Hopkins Medicine, Baltimore. For being a nationally recognized trauma surgeon whose innovative work and exceptional leadership in firearm injury prevention has been most instrumental in establishing the urgency and intellectual foundation to drive research and evidence-based policy change at the local, state, and federal levels.
Rebecca Anne Seguin-Fowler, PhD, RDN, co-director, Institute for Advancing Health Agriculture, and professor of nutrition, Texas A&M University, College Station. For being a leading authority on community-engaged research in the areas of diet and physical activity interventions for obesity and chronic disease prevention among rural, low-income, older adult, minority, and other at-risk, underserved populations. Her innovative work and leadership have advanced knowledge related to social and environmental contextual factors to advance implementation and dissemination research to achieve health equity.
Morgan Sheng, MBBS, PhD, professor, department of brain and cognitive sciences, Massachusetts Institute of Technology; core institute member, Broad Institute of MIT and Harvard, Cambridge. For transforming the understanding of excitatory synapses. He revealed the postsynaptic density as a protein network controlling synaptic signaling and morphology; established the paradigm of signaling complexes organized by PDZ scaffolds; and pioneered the concept of localized regulation of mitochondria, apoptosis, and complement for targeted synapse elimination.
Catherine Y. Spong, MD, professor and Paul C. MacDonald Distinguished Chair, department of obstetrics and gynecology, University of Texas Southwestern Medicine Center, Dallas. For her international leadership, both at NIH during the ZIKA epidemic and at UT-Southwestern during the COVID-19 pandemic, that clearly demonstrated that clinical research translates into improved care for women and families.
Timothy A. Springer, PhD, senior investigator, program in cellular and molecular medicine, and Latham Family Professor, professor of biological chemistry and molecular pharmacology, and professor of medicine, Boston Children’s Hospital/Harvard Medical School, Boston. For his research on receptor-ligand interactions and transmembrane signal transmission that are relevant to immunology, hemostasis, and human disease using structural, cell biological, and single molecule techniques. Molecules studied include integrins and their ligands, TGF-β, the epidermal growth factor receptor, vaccine targets in malaria, and von Willebrand factor (4750).
Brent R. Stockwell, PhD, William R. Kenan Jr. Professor of Biological Sciences; chair, department of biological sciences, and professor of chemistry, Columbia University; and professor of pathology and cell biology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York City. For his discovery of ferroptosis, a form of iron-driven, oxidative cell death involving lipid peroxidation. He defined its features, mechanistic basis, the key genes and proteins and inhibitors that regulate it, and tools to study it. He identified roles of ferroptosis in neurodegenerative diseases and cancer, suggesting novel therapeutic strategies.
Rudolph Emile Tanzi, PhD, Joseph P. and Rose F. Kennedy Professor of Neurology, Harvard University, and vice chair of neurology, Massachusetts General Hospital, Boston. For being a pioneer and world leader in the areas of Alzheimer’s disease (AD), neurogenetics, and translating pathogenetic mechanisms underlying neurodegenerative diseases into novel therapeutics. He discovered numerous AD genes including the first three and developed the first complete human brain organoid model of AD, greatly accelerating drug discovery.
Julian F. Thayer, PhD, distinguished professor, department of psychological science, University of California, Irvine. For groundbreaking research and theory in understanding how stress, including racism, impacts autonomic nervous system dynamics and influence disease and the process of aging. Specifically, he has mapped out the complex mechanisms of how stress-related dysregulation of the vagal-neural axis can lead to early cardiovascular disease.
Methodius Gamuo Tuuli, MD, MPH, MBA, Chace-Joukowsky Professor of Obstetrics and Gynecology; chair, obstetrics and gynecology, Warren Alpert Medical School, Brown University; chief of obstetrics and gynecology, Women and Infants Hospital of Rhode Island; and executive chief of obstetrics and gynecology, Care New England, Providence, R.I. For employing large multicenter trials and cohort studies, in the U.S. and globally, to generate evidence for clinical practice and policy to prevent adverse obstetric outcomes including surgical site infection after cesarean, management of labor, and medical complications in pregnancy, while building research capacity and mentoring diverse scholars.
Robert Otto Burciaga Valdez, PhD, MHSA, director, Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, Rockville, Md. For internationally recognized expertise in health services research and whose research has generated actionable knowledge. His government service, mentoring, and academic leadership have all advanced our ability to measure and improve access, quality, and health care outcomes, especially for children and historically excluded communities.
Terry L. Vanden Hoek, MD, FACEP, professor and department chair of emergency medicine, professor of physiology and biophysics, professor of pharmacology and regenerative medicine, and director, Center for Advanced Resuscitation Medicine, Center for Cardiovascular Research, UI Health, University of Illinois College of Medicine, Chicago. For his leadership in CPR that has changed worldwide practice and significantly improved cardiac arrest survival in Illinois. He has received over $30 million of extramural funding to improve care for vulnerable populations and his work ranges from novel peptide development for cardiac arrest treatment to artificial intelligence-monitoring for COVID-19 patient protection.
Robert H. Vonderheide, MD, DPhil, director, Abramson Cancer Center; John H. Glick Abramson Cancer Center Director’s Professor; vice dean, Cancer Programs, Perelman School of Medicine; and vice president, Cancer Programs, University of Pennsylvania Health System, University of Pennsylvania, Philadelphia. For developing immune combination therapies for patients with pancreatic cancer by driving proof-of-concept from lab to clinic, then leading national, randomized clinical trials for therapy, maintenance, and interception; and for improving access of minority individuals to clinical trials while directing an NCI comprehensive cancer center.
Emily Ai-hua Wang, MD, MAS, professor of medicine and of public health, and director, SEICHE Center for Health and Justice, Yale University School of Medicine, New Haven, Conn. For elucidating the health impacts of incarceration and partnering with formerly incarcerated people to study interventions to prevent health harms. Her work illuminates that the achievement of health equity requires ending mass incarceration and the vital role that health systems can play in decarceration to improve population health.
Jennifer A. Wargo, MD, MMSc, R. Lee Clark Endowed Professor of Surgical Oncology and Genomic Medicine, and founder and director, Platform for Innovative Microbiome and Translational Research, University of Texas MD Anderson Cancer Center, Houston. For making fundamental and practice-changing contributions to our understanding of the response and resistance of melanoma to targeted therapy and immunotherapy. She pioneered the role of the tumor and gut microbiome in tumor biology and therapeutic response and translated these paradigmatic discoveries into novel clinical trials.
Daniel W. Webster, ScD, MPH, Bloomberg Professor of American Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore. For leading groundbreaking research that has shaped policies at all levels of government and the gun violence prevention field. Over 30 years, his research has clearly and unwaveringly identified policies that prevent gun violence and suicides and informed community violence intervention programs.
Jennifer L. West, PhD, dean, School of Engineering and Applied Science, and professor of biomedical engineering, University of Virginia, Charlottesville. For the invention, development and translation of novel biomaterials including bioactive, photopolymerizable hydrogels and theranostic nanoparticles.
Jedd D. Wolchok, MD, PhD, director, Sandra and Edward Meyer Cancer Center, department of medicine, Weil Cornell Medicine, New York City. For his commitment to understanding the role of the immune system in cancer therapy. He has led several practice-changing trials establishing the use of immune checkpoint blockade for melanoma and other cancers. He has also led impactful efforts defining the mechanistic basis for sensitivity to these therapies.
Phillip D. Zamore, PhD, investigator, Howard Hughes Medical Institute; and Gretchen Stone Cook Professor of Biomedical Sciences, and chair and professor, RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester. For making fundamental contributions to the understanding of RNAi, developing the first biochemical systems to study siRNAs, miRNAs, and their protein partners. His seminal discoveries explained how small RNAs are made and repress genes, transposons, and viruses. He has used these insights to develop novel RNA-based therapies for human diseases.
Hongkui Zeng, PhD, executive vice president and director, Allen Institute for Brain Science, Seattle. For her leadership in investigating cell types and connections in the mammalian brain. Her team has generated large-scale, open-access datasets and tools to accelerate neuroscience discovery. By systematically characterizing the transcriptome, morphology, and physiology of individual neurons, her work has led to transformative understanding of cell type diversity.
Yi Zhang, PhD, Fred S. Rosen Chair Professor, department of pediatrics, Boston Children’s Hospital; professor, department of genetics, Harvard Medical School; and associate member, Broad Institute of MIT and Harvard, Boston. For making fundamental contributions to the epigenetics field through systematic identification and characterization of chromatin modifying enzymes, including EZH2, JmjC, and Tet. His proof-of-principle work on EZH2 inhibitors led to the founding of Epizyme and eventual making of tazemetostat, a drug approved for epithelioid sarcoma and follicular lymphoma.
Newly elected international members and their election citations are:
Charles O. Agyemang, PhD, MPH, professor, global migration, ethnicity, and health, University of Amsterdam, Netherlands. For providing novel insight into the effects of global migration on obesity, diabetes, and cardiovascular diseases. He established the RODAM study on Africa-to-Europe migration. His team conducted the first comprehensive research on health outcomes in African migrants in Europe, utilizing epidemiological, social, clinical, and molecular tools.
Celso Arango, MD, PhD, director, Institute of Psychiatry and Mental Health, and head, department of child and adolescent psychiatry, Hospital General Universitario Gregorio Marañón, Madrid, Spain. For facilitating the change in FDA, EMA policies for psychotropic drugs for pediatric indications. He was influential in facilitating regulatory agency policies changes requiring companies to conduct pediatric investigations as part of a new drug’s development. He has led 15 clinical trials in prevention and treatment of mental disorders in children and adolescents.
Lukoye Atwoli, MBChB, MMed Psych, PhD, professor and dean, Medical College East Africa; and associate director, Brain and Mind Institute, The Aga Khan University Medical College, East Africa, Nairobi, Kenya. For contributions to mental health care, policy, education, and epidemiology globally, for leading African and global medical and psychiatric associations, for leading two innovative medical schools in Africa as dean, and for co-chairing the National Academies of Sciences, Engineering, and Medicine’s Board on Global Health, among other achievements.
Nils Brose, PhD, director, department of molecular neurobiology, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany. For his pioneering work that has provided key insights into the molecular topography of synaptic signaling. His discoveries of key principles of synapse formation and transmitter release form the basis of our understanding of how neuronal microcircuits are organized and operate, and how their malfunction causes neurological and psychiatric disorders.
Hélène Carabin, DVM, MSc, PhD, professor and Canada Research Chair in Epidemiology and One Health, department of microbiology and pathology, and faculty of veterinary medicine, department of social and preventative medicine, School of Public Health, Université de Montréal, Montreal, Canada. For her internationally recognized leadership in the epidemiology and transmission of neglected infections and neurological disease using a One Health approach. She currently serves on the scientific advisory committee on Global Health for Canada. Her epidemiological approaches have contributed to establishment of effective measures of zoonotic disease impact and global burden of disease estimates.
Daniel Drucker, MD, professor of medicine, department of medicine, University of Toronto; and senior scientist, Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, Toronto, Canada. For pioneering studies of gastrointestinal hormone action and elucidating multiple novel metabolic actions of GLP-1, DPP-4, and GLP-2. His discoveries enabled development of three new classes of medications (GLP-1R agonists, DPP4 inhibitors, GLP-2R agonists) that have transformed the treatment of diabetes, obesity, and short bowel syndrome.
Christian T. Happi, MSc, PhD, distinguished professor, Redeemer’s University; and director, African Center of Excellence for Genomics of Infectious Diseases (ACEGID), Ede, Nigeria. For his tangible impact on infectious disease research in Africa. He has established critical programs and made important scientific contributions to malaria, Lassa fever, Ebola, mpox, yellow fever, and COVID-19 research. He led the effort to sequence the first full SARS-Cov-2 genome in Africa, which guided public health interventions, and is developing an early warning system that could stop the next pandemic before it starts.
Marta Imamura, MD, PhD, associate professor, department of legal medicine, bioethics, work medicine and physical medicine and rehabilitation, University of São Paulo School of Medicine, São Paulo, Brazil. For her internationally recognized research exploring the role of central and peripheral sensitization and neurophysiological biomarkers contributing to chronic disabling myofascial (musculoskeletal) pain. This work is being evaluated for use by the Brazilian Unified Health System for assessment and non-pharmacological treatment of this pain.
Anne M. Johnson, MB BS, MSc, MD, professor of infectious disease epidemiology, Institute for Global Health, University College London, London, United Kingdom. For being a leading clinical epidemiologist on transmission dynamics and prevention of HIV, sexually transmitted infections, and more recently COVID-19. She has led the British National Surveys of Sexual Lifestyles. Her research has focused on understanding behavioral epidemiology and has contributed broadly to public health policy.
Jens Nielsen, PhD, drtechn, drmedhc, CEO, BioInnovation Institute, Copenhagen, Denmark; professor, department of life science, Chalmers University of Technology, Gothenburg, Sweden. For developing a systems biology approach for studying human metabolism with the objective to identify novel biomarkers and drug targets for metabolic diseases like type-2-diabetes, liver diseases and cancer. Several of his findings have been translated for use in the clinic for improved diagnosis.
Contact:
Dana Korsen, Director of Media Relations
Office of News and Public Information
202-334-2138; e-mail [email protected]
# # #
